Buda Juice Inc. Common Stock (BUDA)

FairStock Score: 39/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for simple consumer businesses with durable demand and a price that leaves room for error. Buda Juice sells clean-label juices and wellness shots, mostly to wholesale customers, so it sits in a defensive category. Revenue is moving: in fiscal year 2025, the year ended 2025-12-31, revenue was $12.6 million versus $11.3 million in fiscal year 2024, the year ended 2024-12-31. More recently, in fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $4.5 million, up from $3.6 million in fiscal Q2 2025, the quarter ended 2025-06-30. But profit is not following. In fiscal Q2 2026, net income was $470,000, down from $1.2 million in fiscal Q2 2025. In fiscal year 2025, net income was $3.5 million versus $3.6 million in fiscal year 2024. The given profit growth of -51.92% tells me margins or costs are under pressure. Financial health looks solid on leverage: debt-to-equity is 0.03 and FairStock's Altman Z-score is 27.41. FairStock calculations show return on equity of 19.30% and return on capital employed of 11.43%. Yet free cash flow is only $1.6 million, a 1.7% FCF yield, which is thin against a $94.2 million market cap. At the 2026-10-13 close of $7.50, FairStock shows a P/E of 39.47, P/B of 4.36, EV/EBITDA of 26.38, and a Graham Number of $2.71, leaving a margin of safety of -176.75%. The FairStock Score is 39/100. I cannot see a durable moat from these figures; the company is small with 39 employees and only two years of filed results, so the Lynch category is none. I would want evidence that profit and cash flow recover before calling this a bargain.

In plain English: Buda Juice makes and sells juices, lemonades, limeades, and wellness shots, mainly to wholesale customers. Sales are growing, but profits have fallen, and at $7.50 the stock looks expensive compared with the company's earnings and cash generation. The company has little debt, which is a plus, but the business looks only fair and the price does not look cheap.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · fiscal Q1 2025 10-Q (period ended 2025-03-31) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer